Antiviral drugs

4-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine.

4-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine.

4-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine.

4-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine.

Synonyms: p-Nitrophenyl-a-L-fucoside CAS No.: 10231-84-2 Molecular Formula: C12H15NO7 Molecular Weight: 285.25 MDL No.: MFCD00063697 Storage Temperature: Store at 0-8°C

4-Pentynoic acid undergoes copper-catalyzed intramolecular cyclizations to form enol lactones . It also reacts with 1-bromo-1-alkynes in the presence of a Pd catalyst to yield biologically active ynenol lactones .

4-Pentynoic acid undergoes copper-catalyzed intramolecular cyclizations to form enol lactones . It also reacts with 1-bromo-1-alkynes in the presence of a Pd catalyst to yield biologically active ynenol lactones .

4-phenyl-1-sulfanyl-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one.

4-phenyl-1-sulfanyl-4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-5-one.

4-PIPERIDIN-1-YL-2-PYRIDIN-2-YL-QUINOLINE-

Reactant for synthesis of: Ursolic acid derivatives Amodiaquine analogues for treatment of cerebral malaria Spiroimidazolidinone NPC1L1 inhibitors Piperazinyl glutamate pyridines as orally bioavailable P2Y12 antagonists for inhibition of platelet

Reactant for synthesis of: Ursolic acid derivatives Amodiaquine analogues for treatment of cerebral malaria Spiroimidazolidinone NPC1L1 inhibitors Piperazinyl glutamate pyridines as orally bioavailable P2Y12 antagonists for inhibition of platelet